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Abstract
The antioxidant vitamin E is a commonly used vitamin supplement. Although the multi-billion dollar vitamin and nutritional supplement industry encourages the use of vitamin E, there is very little evidence supporting its actual health benefits. Moreover, vitamin E is now marketed as a
lipid raft destabilizing anti-cancer agent, in addition to its antioxidant behaviour. Here, we studied the influence of vitamin E and some of its vitamers
on membrane raft stability using phase separating unilamellar lipid vesicles
with small angle scattering techniques and fluorescence microscopy. We find
that lipid phase behaviour remains unperturbed well beyond physiological
concentrations of vitamin E (up to a mole fraction of 0.10). Our results
Preprint submitted to Biochimica et Biophysica Acta

January 7, 2020

are consistent with a proposed line active role of vitamin E at the domain
boundary. We discuss the implications of these findings as they pertain to
lipid raft modification in native membranes, and propose a new hypothesis
for the antioxidant mechanism of vitamin E.
Keywords: Vitamin E, α-tocopherol, γ-tocopherol, Lipid rafts, Small-angle
neutron scattering, Lipid bilayer

1

1. Introduction

2

Vitamin E was discovered in 1922 by Evans and Bishop as a vital dietary

3

biomolecule for mammalian reproduction. Yet, to this day its precise biolog-

4

ical role continues to be debated [2, 3, 4]. Vitamin E refers to two families

5

of molecules known as tocopherols and tocotrienols, each comprised of four

6

members (α, β, γ, and δ) differing in methylation of their chromanol ring (see

7

Figure 1). Considering this somewhat minor structural difference between

8

family members, and the fact that all species are regularly consumed in the

9

average diet, it is remarkable that α-tocopherol is the only one of the eight

10

variants actively retained by the human body [5, 6].

11

A large body of literature advocates that vitamin E is the first line of

12

defense for cell membranes against oxidation [8, 9]. As a result, vitamin E

13

is commonly used as a bio-compatible preservative in the cosmetic and food

14

industries [7]. However, and to the best of our knowledge, the role of vitamin

15

E in vivo remains ambiguous. Some studies allude to a role in homeostatic

16

processes, and deficiency of vitamin E leads to diseases such as infertility and

17

neuromuscular dysfunction, all without elucidated mechanisms [1, 10]. The

18

lack of good experimental evidence and the fact that vitamin E is found in

2
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Figure 1: Structures of the tocopherol members of the vitamin E family. Here we examine:
α-tocopherol (αToc) the species preferentially taken-up by the human body; γ-tocopherol
(γToc) the most naturally abundant species [7]; and the stable oxidation product of αToc,
α-tocopherylquinone (αTocQ).

19

extremely low concentrations in vivo [11], calls into question its antioxidant-

20

centric role [4].

21

It is not surprising that vitamin E properties are propagated by industry

22

and health professionals that advocate for the sale of dietary supplements.

23

Across North America, an estimated sixty percent of middle-to-late-aged

24

adults consume vitamins, including vitamin E, while sufficient recommended

25

amounts can generally be obtained from a balanced diet [12]. Nutrition

3

26

companies offer a variety of vitamin E supplements ranging from pure RRR-

27

α-tocopherol to “natural” mixtures containing all of the tocopherol family

28

members, often in amounts ranging from 3 to 30 times the recommended

29

daily intake [7]. While the health benefits of sufficient dietary antioxidants

30

are well documented, vitamin E is also marketed for promoting cardiovascular

31

health and as an anti-cancer agent [13, 14].

32

The rationale for vitamin E as an anti-cancer agent is predicated on a

33

proposed mechanism of membrane raft destabilization [15]. Cell membranes

34

have been implicated in a vast array of cellular processes, which can often

35

be facilitated by the lateral organization of lipids and proteins into micro

36

and nanoscale “rafts” [16, 17]. It is thought that certain varieties of cancer

37

cells, particularly prostate and breast, possess more robust lipid rafts that

38

can be destabilized through cholesterol depletion by raft-modulating agents

39

such as methyl-β-cyclodextrin [18, 15, 19]. This hypothesis has thus inspired

40

many studies investigating the potential anti-cancer effects of vitamin E.

41

Notably, Yang et al. have suggested that high-dose supplementation of γ- and

42

δ- tocopherols inhibits tumorigenesis, while α-tocopherol does not [20, 21, 22].

43

Conversely, clinical trials involving α-tocopherol supplementation indicate an

44

increased risk for developing prostate cancer in healthy men [14, 13].

45

Observations of membrane rafts have been elusive in live cells, presumably

46

due to their proposed small size and transient nature, in addition to the

47

inherent complexity of biological membranes [23, 24]. More recently, lipid

48

domains on the order of 40 nm in size were observed in living bacteria [25].

49

Three-component lipid mixtures mimicking the outer leaflet of eukaryotic

50

plasma membranes are commonly used as model systems for the study of

4

51

lipid rafts [26, 27]. Specifically, vesicles composed of high- and low-melting

52

lipids, and cholesterol are thermodynamically unstable and demix into a

53

cholesterol-rich liquid ordered (Lo ) phase that coexists with a cholesterol-

54

poor liquid disordered (Ld ) phase. These structures are compatible for study

55

by a range of biophysical techniques, including small-angle neutron and X-ray

56

scattering [28], and fluorescence microscopy [29, 30, 31].

57

In the current study we looked at how vitamin E affects lipid membranes,

58

and if its behaviour is consistent with raft-disrupting anti-cancer mechanisms,

59

in the hope of gaining a better understanding of vitamin E supplementation.

60

2. Materials and Methods

61

2.1. Materials

62

1,2-dipalmitoyl-sn-glycero- 3-phosphocholine (16:0/16:0 PC, DPPC), 1,2-

63

dipalmitoyl-d62-sn-glycero-3-phosphocholine (16:0[d31]/16:0[d31] PC, d62-

64

DPPC), 1,2-dioleoyl-sn-glycero-3-phosphocholine (18:1/18:1 PC, DOPC), and

65

1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-(lissamine rhodamine B

66

sulfonyl) (LR-DPPE) were purchased from Avanti Polar Lipids, Inc. (Al-

67

abaster, AL). Cholesterol, DL-all-rac-α-tocopherol (α-tocopherol, αToc), (R,R,R)-

68

γ-tocopherol (γ-tocopherol, γToc), D-α-tocopherylquinone (α-tocopherylquinone,

69

αTocQ), and sucrose were purchased from Sigma-Aldrich (St. Louis, MO).

70

Naphtho-[2,3-a]pyrene (naphthopyrene) was purchased from TCI America

71

(Tokyo, Japan). 99.9 % D2 O was purchased from Cambridge Isotopes (An-

72

dover, MA). All reagents were used without further purification.
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73

2.2. SANS Sample Preparation

74

2.2.1. Selection of Lipid Composition

75

All experiments were performed using a mixture of DPPC/DOPC/Chol

76

at a mole ratio of 37.5/37.5/25, respectively. This composition contains a

77

1:1 ratio of high- and low-melting lipids such that the area fractions of Lo

78

phase and Ld phase domains are approximately equal. The phase behaviour

79

of this composition has carefully been characterized by different techniques

80

in a number of previous studies, thereby offering a reliable foundation for

81

this work [30, 32, 33].

82

2.2.2. Preparation of Unilamellar Vesicles

83

Well-established protocols were followed to prepare unilamellar vesicles

84

(ULVs) for scattering measurements. In brief, lipid mixtures were prepared

85

by transferring desired volumes of stock solutions in HPLC-grade chloro-

86

form to a scintillation vial using a glass syringe (Hamilton USA, Reno, NV).

87

Lipid films were formed through chloroform evaporation under a gentle argon

88

stream, followed by trace solvent removal in vacuo for >12 hours. The films

89

were hydrated to 20 mg/ml by the addition of a 34.6% D2 O/H2 O mixture,

90

and incubated for 30 minutes at 50 ◦ C prior to the formation of a multilamel-

91

lar vesicle (MLV) suspension by vortexing. The ratio of D2 O/H2 O was used

92

to replicate the contrast matching scheme described by Heberle et al., such

93

that the scattering length density of the aqueous solvent is simultaneously

94

matched to the that of the lipid headgroup and average hydrocarbon chain

95

compositions. This contrast matching scheme minimizes scattering contri-

96

butions arising from transverse (i.e., normal to the plane of the bilayer)

97

scattering length density variation, and emphasizes scattering contributions
6

98

arising from in-plane heterogeneity (i.e., demixing of saturated and unsat-

99

urated chains) [34]. The MLV suspension was subjected to 5 freeze/thaw

100

cycles between -80 ◦ C and 50 ◦ C, followed by vortexing at 50 ◦ C. ULVs were

101

then prepared by 31 passes through a hand-held miniextruder equipped with

102

a 50 nm pore-diameter polycarbonate filter (Avanti Polar Lipids, Alabaster,

103

AL) and heated to 50 ◦ C. Extruded vesicles were characterized by dynamic

104

light scattering on a Malvern ZetaSizer Nano ZS (Malvern Panalytical, Ltd.,

105

Malvern, UK).

106

2.3. Characterization of Phase Separation by Contrast-Matched SANS

107

Neutron scattering experiments were performed at the Very Small-Angle

108

Neutron Scattering (NG3-VSANS) instrument located at the National Insti-

109

tute of Standards and Technology Center for Neutron Research (NIST-CNR).

110

The white beam option was configured to use a neutron wavelength of 5.3

111

Å with a ∆λ/λ of 40%. Data were collected using two detector carriages

112

positioned at sample-to-detector distances of 5.4 m and 13 m. This single

113

configuration and large wavelength spread results in lower q-resolution, but

114

allows for higher flux at the point of the sample, and thus shorter count

115

times. In this case, good quality data in a scattering vector range of 0.009

116

Å−1 < q < 0.5 Å−1 were acquired in three minutes.

117

Additional experiments were performed at the CG-3 Bio-SANS instru-

118

ment of the High Flux Isotope Reactor (HFIR) located at Oak Ridge Na-

119

tional Laboratory (ORNL). Data were taken at a sample-to-detector distance

120

of 15.5 m using 6 Å wavelength neutrons (fwhm 15%). A total scattering

121

vector of 0.003 Å−1 < q < 0.8 Å−1 was collected using a two-dimensional

122

(1 m × 1 m)

3

He position-sensitive detector (ORDELA, Inc., Oak Ridge,
7

123

TN) with 192 × 256 pixels in combination with a 1 m × 0.8 m wing detector

124

comprised of 160 × 256 pixels and rotated by 1.40◦ .

125

ULV suspensions of 20 mg/ml were loaded into 1 mm path-length banjo

126

cells (Hellma USA, Plainview, NY) and mounted in a Peltier temperature-

127

controlled cell holder with ≈1 ◦ C accuracy. Samples were measured at 7 tem-

128

peratures, ranging from the two-phase (Lo / Ld ) liquid coexistance regime at

129

lower temperatures through to the uniformly melted Ld phase at higher tem-

130

peratures. At a minimum, samples were permitted to equilibrate at each tem-

131

perature for 20 minutes prior to measurement. Data were reduced, stitched,

132

and corrected for detector pixel sensitivity, dark current, sample transmis-

133

sion, and background scattering from water using ORNL’s Mantid software

134

(BioSANS) [35] or the appropriate Igor Pro macros (VSANS) provided by

135

NIST-CNR [36].

136

137

The resulting data were analyzed in a model-independent manner using
the Porod invariant to represent the total scattering intensity [37]:
Z
Q=

∞

q 2 I(q)dq

(1)

0
138

With the contrast matching scheme used here, Q to a first approximation

139

is only dependent on the area fraction of the Lo phase (aLo ) and the difference

140

in contrast between the Lo and Ld domains (∆ρ) [38]:
Q ≈ aLo (1 − aLo )∆ρ2

(2)

141

Since neutron contrast depends on how strongly the deuterated and proti-

142

ated lipids are segregated, SANS measurements can detect changes in domain

143

area fraction (aLo ) or a change in the partitioning of the lipids between the
8

144

coexisting phases. For example, either a decrease in domain area fraction,

145

or reduced partitioning of saturated and unsaturated lipids between the two

146

phases, will cause a decrease in the total scattering according to Eq. 2. Both

147

of these features imply a destabilization of lipid domains.

148

2.4. Bilayer Structure from SAXS

149

Small angle X-ray scattering (SAXS) experiments were performed on the

150

same samples measured by SANS. ULVs at a concentration of 10 mg/ml were

151

measured using a Rigaku BioSAXS-2000 (Rigaku Americas, The Woodlands,

152

TX) equipped with a Pilatus 100K detector and an HF007 rotating copper

153

anode source. All samples were measured above the phase transition tem-

154

perature (50 ◦ C) to ensure well mixed bilayers. Multiple measurements were

155

obtained for each sample, and samples were monitored for radiation damage

156

before averaging. Resulting form factors in the scattering vector range of

157

0.04 Å−1 < q < 0.6 Å−1 were background-corrected using PRIMUS [39] and

158

modeled using the Global Analysis Program (GAP) developed by Pabst et al.

159

[40, 41].

160

2.5. Preparation and Fluorescence Imaging of Giant Unilamellar Vesicles

161

Giant unilamellar vesicles (GUVs) suitable for epifluorescence microscopy

162

were generated using a modified electroformation protocol as described by

163

Konyakhina and Feigenson [42, 43]. In brief, lipid mixtures with and without

164

a vitamin E mole fraction of 0.10 (χ = 0.10) were mixed in chloroform and

165

combined with fluorescent probes at predefined mole ratios. The mixture

166

was then spread evenly onto a conductive indium tin oxide (ITO)-coated

167

slide (Delta Technologies, LTD., Loveland, CO). The fluorescent probes
9

168

(χLR−DP P E = 0.005 and χnaphthopyrene = 0.01) were chosen based on their

169

known lipid phase partitioning behavior [44]. Solvent was removed by overnight

170

drying in vacuo for >12 hours. GUVs were then formed in 100 mmol/L

171

aqueous sucrose by heating for 1 h at 50 ◦ C with electroformation by a 10

172

Hz sinusoidal current with a peak-to-peak amplitude of 1 V. The samples

173

were gradually cooled to room temperature over 10 h using a Digi-Sense

174

benchtop temperature controller (Cole Parmer, Vernon Hills, IL) to mini-

175

mize kinetically-trapped domain artifacts. GUVs were transferred to a glass

176

coverslip enclosed by a silicon gasket, sealed by a glass slide, and allowed to

177

settle for 1 h prior to imaging. All samples were imaged at ambient tempera-

178

ture within 24 h of preparation using an inverted epifluorescence microscope

179

(Leica DMI6000, Wetzlar, Germany). LR-DPPE was detected using a Texas

180

Red filter cube (ex. 594 nm / em. 598 nm) and naphthopyrene was detected

181

using a DAPI filter cube (ex. 357 nm / em. 459 nm). Care was taken to

182

prevent light-induced phase separation by minimizing illumination intensity

183

and exposure [45, 46]. Resulting images were artificially recoloured for pub-

184

lication using the Leica LAS X software to improve accessibility for readers

185

with vision impairment.

186

3. Results and Discussion

187

3.1. Tocopherol does not affect bilayer structure

188

Phase separating ULVs suspended in water were heated to 50 ◦ C to en-

189

sure a uniform distribution of the lipids, thus ensuring a bilayer of uniform

190

thickness suitable for structural studies by SAXS. To quantify any differences

191

in bilayer structure, the scattering form factors were modeled using the GAP
10

192

program to determine physical parameters [40, 41]. GAP models an electron

193

density profile of the bilayer by parameterizing three Gaussians, one for each

194

electron-rich head group and one for the hydrocarbon region. As X-rays are

195

sensitive to the electron-rich phosphates in the lipid head groups, we report

196

the headgroup-headgroup distance of the bilayers (dHH ) from the optimized

197

modelled form factor. Note, dHH is directly determined and requires no sub-

198

sequent calculations or assumptions about the system. As explained in the

199

SI, due to the complexity of the multi-component systems, some parameters

200

were fixed to refine the fit.

201

Table 1 summarizes dHH for each composition explored and additional fit

202

parameters are shown in Table S1 of the Supplementary Material. Mea-

203

sured headgroup-headgroup distances for DPPC/DOPC/Chol are consis-

204

tently within 2% of previously reported values [33, 47, 48]. Interestingly,

205

up to a mole fraction of 10% tocopherol, the transverse bilayer structure is

206

not significantly perturbed. The slight thinning of the bilayer upon addi-

207

tion of tocopherol is likely an artifact of fixing the width of the Gaussian

208

describing the headgroup, σH. Due to the orientation of tocopherol in the

209

membrane, with its chromanol headgroup residing at the hydrophilic inter-

210

face [49, 50, 51], additional electron density will be present slightly inside the

211

headgroup Gaussian, which is best described by a wider σH and an asym-

212

metric Gaussian. Since the GAP program cannot parameterize for skewed

213

Gaussians, it compensates for this distribution by shifting the position of the

214

headgroup, zH, closer to the bilayer center. This trend is most dramatic for

215

αTocQ, though only 1.4 Å thinner, where the electron-rich benzoquinone

216

head contributes to a greater proportion of the electron density within the

11

217

bilayer, just beyond the phosphate group. Indirectly, this suggests that both

218

γToc and αTocQ are likely to localize in the membrane similarly to αToc,

219

consistent with past neutron diffraction observations [51].
Table 1: Bilayer thickness, represented by the headgroup-headgroup distance, DHH , as a
function of percent tocopherol. Parameters were derived from modelling small angle X-ray
scattering data, with uncertainties defined as 2%

Composition

DHH (Å)

DPPC/DOPC/Chol

39.9 ± 0.8

+ 2 % αToc

39.2 ± 0.8

+ 5 % αToc

39.2 ± 0.8

+ 2 % γToc

39.7 ± 0.8

+ 10 % γToc

39.2 ± 0.8

+ 2 % αTocQ

39.1 ± 0.8

+ 10 % αTocQ

38.5 ± 0.8

The following parameters were fixed based on physical considerations as described in
the SI [47]: width of Gaussian describing the phosphatidylcholine headgroup, σH =
3.0 Å, and amplitude of the Gaussian describing the hydrocarbon tail, relative to that
of the headgroup, ρC = -1.0. All fit parameters are tabulated in Table S1.

220

3.2. Tocopherol destabilises microscopic phase separation

221

GUVs are widely used as models for probing the existence and mor-

222

phology of phase separation at the microscopic level. In this study, the

223

DPPC/DOPC/Chol 37.5/37.5/25 system displays robust hemispherical do-

224

mains that can be visualized by the selective partitioning of naphthopyrene

225

and LR-DPPE into the Lo and Ld membrane environments, respectively (Fig.
12

226

2A) [44]. At ambient temperature, the addition of χ = 0.10 α- (Fig. 2B) or

227

γ- tocopherol (Fig. 2C) appears to abolish the phase separation, although

228

the presence of domains smaller than the optical resolution limit (≈ 200 nm)

229

cannot be ruled out. Similar suppression of phase separation is observed

230

by heating the system to a point where the mixing entropy, which favours

231

the random arrangement of lipids, dominates over the non-ideal enthalpic

232

contribution to free energy, and results in increased acyl chain disorder and

233

increased lateral lipid diffusion.

234

In contrast to α- and γ-tocopherol, the presence of α-tocopherylquinone

235

(αTocQ), even up to a mole fraction of 0.10, does not appear to change the

236

phase behaviour (Fig.2D).

237

3.3. Domain perturbations described by SANS

238

Contrast-matched SANS is a powerful tool to probe the lateral orga-

239

nization of lipids along the bilayer and from SANS one is able to extract

240

precise structural features. An example of this is provided by the model-

241

ing of SANS data to determine domain size in refs [34, 52]. According to

242

the work of Pencer et al., due to the dependence of the scattering function

243

on contrast, lateral segregation of deuterated and protiated lipids into do-

244

mains yields a scattering contribution that directly correlates to the extent

245

of phase separation. With this experimental design, data can be reduced to a

246

model-independent scalar quantity known as the Porod invariant, Q (Eq. 2)

247

representing the total scattering arising from system contrast [38]. Using this

248

approach, phase behaviour can easily be obtained from the low q-resolution

249

scattering of laterally heterogeneous vesicles. Using a DPPC/DOPC/Chol

250

system, Figure 3(A) shows the difference in scattering obtained by varying
13

Figure 2: Fluorescence microscopy of GUVs composed of (A) DPPC/DOPC/Chol; (B) +
χ = 0.10 αToc; (C) + χ = 0.10 γToc and (D) + χ = 0.10 αTocQ. Naphthopyrene (blue)
preferentially localizes in the Lo phase and LR-DPPE (red) in the Ld phase. Subsequent
acquisitions of each fluorophore are colour-merged to highlight the different phases. Phase
separation is observed in the undoped system (A) and in the presence of αTocQ (D), but
is not observed with αToc (B) or γToc (C).

Temperature = 21 ◦ C. Scale bar = 25 µm.
251

the q-resolution. High q-resolution data were collected at CG3-BioSANS

252

(HFIR, ORNL) and low q-resolution data at NG3-VSANS (NCNR). By ex-

253

tracting the Porod invariant and normalizing to a relative scale bound by the

254

highest contrast (lowest temperature) and lowest contrast (highest tempera-

255

ture), the temperature dependence of phase separation between samples can

256

be directly compared (Fig. 3B). From this normalized scattering intensity,

257

Qnorm , it can be shown that the decay in scattering intensity is not depen-

258

dent on q-resolution. The low and high q-resolution data were obtained from

259

different sample preparations of the same composition, and differences in
14

260

samples may account for the small variations in decay at 25 ◦ C. The low q-

261

resolution “white beam” of VSANS allows for rapid data collection resulting

262

in high sample throughput. However, due to the large wavelength spread,

263

∆λ
,
λ

264

and the inset to Figure 3(A). As a result, modeling the domain size in a fash-

265

ion similar to Bolmatov et al. is not a viable approach [53]. Nevertheless,

266

the use of the VSANS’ “white beam” option provides a 4x increase in flux

267

over conventional SANS experiments and is particularly useful for measuring

268

labile samples that may change during the data acquisition time required to

269

collect good quality data on a conventional SANS instrument.

structural features are lost, as demonstrated by comparing Figure 3(A)

270

Low q-resolution SANS curves featured in Figure 4 show a decrease in

271

scattering intensity as a function of increasing temperature. Phase separa-

272

tion in samples were confirmed to be thermodynamically stable and free of

273

hysteresis effects by measuring sequential heating and cooling scans (Figure

274

S2).

275

The decrease in scattering intensity is a result of less contrast between the

276

lipid phases as they become more miscible, induced by increasing temperature

277

and the addition of tocopherol. Phase separation has been proposed to have

278

biological implications, particularly at the level of protein regulation [54, 55].

279

Though we must be cautious in extrapolating results from vesicle models

280

to biology, this result may suggest that less distinction in the properties of

281

the two phases may diminish the efficacy of segregating membrane proteins

282

solely on the basis of phase preference.

283

While valuable, the SANS form factors (Fig.4) do not offer a clear com-

284

parison between the different lipid compositions. By reducing the data to

15

Figure 3: Comparison of different q-resolution SANS data. (A) Low resolution scattering
from DPPC/DOPC/Chol as a function of temperature from 15 ◦ C (blue) to 45 ◦ C (red).
The inset shows high q-resolution data from the same sample composition. A logarithmic scale is used to emphasize the difference between the form factors. (B) Normalized
scattering intensity (Q) as a function of temperature extracted from both the low- (black
circles) and high-resolution (grey squares). Error is defined as one standard deviation and
error bars are smaller than the data markers.

285

Q and normalizing each sample with the bounds of the DPPC/DOPC/Chol

286

system in the absence of tocopherol, we are able to directly compare changes

287

to the membrane by the presence of tocopherol. These trends are shown in

288

Figure 5, which represents the structurally-independent total scattering from

289

domains as a function of temperature. Remarkably, there is little apprecia-

290

ble deviation in total scattering for samples containing χ = 0.02 or χ = 0.05
16

Figure 4: SANS intensity as a function of temperature and membrane composition. ULVs
of DPPC/DOPC/Chol and DPPC/DOPC/Chol +αToc, +γToc, and +αTocQ at a mole
fraction of 0.10 were measured at (15, 18, 25, 31, 34, 37, and 45) ◦ C. The presence of
different tocopherols modulates both scattering intensity and the rate of intensity decay.
Plots show 0.009 Å−1 < q < 0.05 Å−1 to highlight the difference in scattering at low q.

291

αToc or γToc, however, domains appear to destabilize at higher (χ = 0.10)

292

concentrations. Moreover, due to the strong similarity between the effects

293

of αToc and γToc on phase behaviour, we suggest that this is likely not a

294

determinant in biological selectivity for αToc.

295

It is noteworthy that even at a high concentration, Q is not totally abol-

17

Figure 5:

Normalized total scattering (Q) measured by low q-resolution SANS.

DPPC/DOPC/Chol samples containing χ = 0 (; black), χ = 0.02 (◦; green), χ =
0.05 (4; blue) and χ = 0.10 (♦, orange) of the vitamin E analogues αToc (top), γToc
(middle), and αTocQ (bottom). The mixtures were measured in the temperature range
of 15-45 ◦ C. Smooth curves were added to assist in visualizing trends in the data. Error
is defined as one standard deviation and error bars are smaller than the data markers.

18

296

ished, indicating that the membrane may not be homogeneous, but still con-

297

tains nanoscale lateral heterogeneities. More likely, however, residual scat-

298

tering intensity is a remnant of the inability to contrast match contributions

299

from both lateral and transverse contrast simultaneously.

300

There are many proposed mechanisms of nanodomain stabilization, in-

301

cluding coupling of bilayer composition and curvature inducing a microemul-

302

sion [56], line tension competing with a long range repulsive force [57], or

303

Ising-like critical fluctuations [58]. Our data do not allow us to discriminate

304

between these or other proposed theories of nanodomain stabilization. The

305

most recently reported mechanism that has been suggested for vitamin E is

306

that of a linactant-induced microemulsion [34, 59, 60, 61].

307

Muddana et al. previously explored the phase activity of αToc using

308

coarse-grained Molecular Dynamics simulations to complement GUV mi-

309

croscopy observations [60]. Their results indicate αToc localizes to the do-

310

main interface, thereby acting as a linactant to destabilize macrodomains.

311

We must stress that with SANS we cannot comment on the localization of

312

individual molecules, and though we cannot directly lend support to the

313

mechanism proposed by Muddana et al., our results are qualitatively consis-

314

tent. In fact, one cannot claim for certain a linactant mechanism without

315

verifying that the molecule preferentially localizes to the phase boundary.

316

Our DPPC/DOPC/Chol system is classified as a Type II phase-separating

317

mixture, which produces macroscopic hemispherical domains [26]. The large

318

domains result from high line tension due to a large hydrophobic thickness

319

mismatch between the coexisting phases [34, 62, 63]. The linactant theory

320

postulates that the addition of molecules that partition preferentially to do-

19

321

main interfaces should lower the line tension and result in smaller domains.

322

This theory has gain more traction recently as Yang et al. showed that αToc

323

can minimize line tension at domain boundaries as a means of protecting

324

against HIV gp41-mediated membrane fusion [61].

325

In the case of αTocQ, the effect on lipid segregation is significantly less

326

pronounced. In fact, there is an apparent increase in domain stability with

327

even small amounts of αTocQ. Taken together, our results could lead to

328

speculation of a physiological benefit for an effective membrane antioxidant.

329

Phase boundaries have been identified as a favourable site for membrane

330

permeation [64]. As suggested by Yang et al., tocopherol stabilizes domain

331

interfaces to produce a less permeable boundary [61]. Considering the theory

332

described by Cruzeiro-Hansson and Mouritsen [65] and refined by Cordeiro

333

[66], a reduction in bilayer thickness mismatch reduces the possibility of pore

334

mediated permeation of oxidants. In the instance of membrane oxidation, the

335

initial formation of hydroperoxide lipids promotes the formation of domain

336

interfaces [67], which would be stabilized by present tocopherols. As oxida-

337

tion progresses, chemistry evolves the stable products α-tocopherylquinone

338

and truncated lipids which together drives phase separation [68]. This final

339

increase in lipid raft stability is a potential signal to recruit key proteins to

340

recover or terminate the cell. In this manner, tocopherol would offer a new

341

dimension to its antioxidant activity by protecting the cell membrane from

342

oxidation induced lateral organization and permeation.

343

Again, we must be cautious in extending these observations into the phys-

344

iological realm. The phase modulation we observe arises at vitamin E con-

345

centrations that have not been physiologically observed, even with extensive

20

346

supplementation [11].

347

4. Conclusion

348

In an effort to begin testing a proposed mechanism of vitamin E’s anti-

349

cancer action, we reported on the effect that different members of the vitamin

350

E family have on lipid domains. Data were collected using two different

351

SANS configurations and microscopy, all of which yield consistent results

352

with regards to vitamin E’s influence on membrane organization. Though

353

its phase behaviour is consistent with its membrane-protective role when in

354

concentrations ranging between 0.0001 < χ < 0.004 [11], the lack of lipid

355

domain response at χ = 0.02 αToc or γToc strongly suggests that increased

356

vitamin E intake does not destabilize domains, as has been proposed. With

357

regard to the complexity and variety of phase-active compounds in the native

358

membrane, it seems unlikely that a local mole fraction of vitamin E greater

359

than 0.02 is a definite actuator of domain stability. Therefore, the present

360

work scrutinizes the validity of supplementing vitamin E as a presumed anti-

361

cancer agent.
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